Healthy Skepticism Library item: 5718

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Ahmad SR.
Lilly’s misleading promotion
Lancet 1994; 344:464-465

Abstract:

The Food and Drug Administration has sent a warning letter to Eli Lilly about misleading promotion of its ulcer drug Axid (nizatidine).

Keywords:
*news story/United States/FDA/Food and Drug Administration/ Eli Lilly/ quality of information/ regulation of promotion/EVALUATION OF PROMOTION: GENERAL QUALITY OF INFORMATION/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION